Deepnoid Has Six Abstracts Accepted at KCR 2025
Oral Presentation on the Clinical Utility of the M4CXR Model
Deepnoid, a first-generation medical artificial intelligence (AI) development company in Korea, announced on September 18 that six research abstracts related to its chest X-ray AI diagnostic technology have been accepted for presentation at the Korean Congress of Radiology 2025 (KCR 2025).
KCR is an academic conference on radiology organized by the Korea Society of Radiology. This year's event will be held at Hall B of COEX in Seoul from September 24 to 27. In celebration of the 80th anniversary of the Korea Society of Radiology, the scale of participation has been expanded. Leading global experts in radiology will gather to share the latest diagnostic techniques and research achievements.
Among the accepted abstracts, two are studies related to Deepnoid's "M4CXR" technology and will be presented orally at the conference. The main topics include: ▲ a study on a chest X-ray dual reading system utilizing a vision-language model, and ▲ quantitative and qualitative evaluation of draft radiology reports generated by M4CXR using real clinical chest X-ray data. In addition, four other studies on chest X-ray AI diagnostics will be released as poster presentations during the conference.
Park Jongkwon, head of Deepnoid's AI Advanced Technology Team and the presenter of the oral sessions, stated, "It is significant that our core technology research related to M4CXR has been selected for oral presentation just as we approach commercialization. We will continue to focus on developing medical AI technologies that meet the needs of clinical practice."
Hot Picks Today
Samsung Electronics Introduces New "Special Performance Bonus" for Semiconductors, Paid Entirely in Company Shares
- "Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "US-Iran: Patch-Ups More Likely Than Settlement... Unlikely to Resolve Within 6 Months" [Economic Policy Zoom-In]
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
M4CXR, a multimodal generative AI-based medical device, interprets 41 types of chest X-ray lesions and generates a highly reliable draft radiology report within seconds. Last month, it received approval from the Ministry of Food and Drug Safety for a digital medical device clinical trial plan and is currently conducting a multi-center, retrospective, confirmatory clinical trial. The company is pursuing commercialization in stages through obtaining medical device approval and reimbursement listing.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
